| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:12052606 | ||||
| van Vliet HA et al. | Biphasic versus triphasic oral contraceptives for contraception. | 2002 | Contraception | pmid:12057781 |
| Perry W and Wiseman RA | Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: effect on lipids, coagulation factors, haematology and biochemistry. | 2002 | Maturitas | pmid:12065175 |
| Zitzmann M et al. | Contraceptive steroids influence the hemostatic activation state in healthy men. | 2002 Jul-Aug | J. Androl. | pmid:12065457 |
| Schnare SM | Progestin contraceptives. | 2002 May-Jun | J Midwifery Womens Health | pmid:12071381 |
| Kawecka-Jaszcz K et al. | The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. | 2002 | J Hum Hypertens | pmid:12080436 |
| Mitwally MF et al. | Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. | 2002 Jul-Aug | Menopause | pmid:12082359 |
| Mueck AO et al. | Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. | 2002 Jul-Aug | Menopause | pmid:12082363 |
| Denton AS et al. | Systematic review for non-surgical interventions for the management of late radiation proctitis. | 2002 | Br. J. Cancer | pmid:12107832 |
| Cheng S et al. | Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women. | 2002 | Bone | pmid:12110425 |
| Madsen JS et al. | Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. | 2002 | Am. J. Obstet. Gynecol. | pmid:12114885 |
| pmid:12135796 | ||||
| Ramachandra SG et al. | Effect of chronic administration of 7alpha-methyl-19-nortestosterone on serum testosterone, number of spermatozoa and fertility in adult male bonnet monkeys (Macaca radiata). | 2002 | Reproduction | pmid:12141943 |
| Wells M et al. | Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. | 2002 | BMJ | pmid:12153918 |
| Harrison RF et al. | Comparison of serial PGF 2alpha concentrations in serum of normal women and in those receiving oral contraceptives. | 1975 | Prostaglandins | pmid:1215535 |
| Miyaji K | [Studies on inhibitors of blood coagulation and fibrinolysis during use of oral contraceptives]. | 1982 | Nihon Funin Gakkai Zasshi | pmid:12158577 |
| Simsek T et al. | Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system. | 2002 | Maturitas | pmid:12161049 |
| Williams JG and Williams KI | Metabolism of 2-3H- and 4-14C-17alpha-ethynylestradiol 3-methyl ether (mestranol) by women. | 1975 | Steroids | pmid:1216258 |
| Graff-Iversen S and Tonstad S | Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey. | 2002 | Contraception | pmid:12169374 |
| Beck LR and Pope VZ | Long-acting injectable norethisterone contraceptive system: review of clinical studies. | 1984 | Res Front Fertil Regul | pmid:12179635 |
| pmid:12180549 | ||||
| Oehler MK et al. | Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia. | 2002 | Cancer Lett. | pmid:12183078 |
| Ylikorkala O et al. | Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate. | 2002 | Acta Obstet Gynecol Scand | pmid:12190841 |
| Ranta V et al. | National differences in lipid response to postmenopausal hormone replacement therapy. | 2002 | Maturitas | pmid:12191848 |
| Posaci C et al. | The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy. | 2002 | Maturitas | pmid:12191850 |
| Tatsumi H et al. | Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. | 2002 | Maturitas | pmid:12191851 |
| Panay N et al. | Low dose 25 mg oestradiol implants and 1 mg norethisterone as continuous combined hormone therapy: a prospective study. | 2002 | BJOG | pmid:12197380 |
| Konno A et al. | Oral contraceptives worsen endotoxin-induced liver injury in rats. | 2002 | Alcohol. Clin. Exp. Res. | pmid:12198379 |
| Neill AC et al. | A comparison of clinical assessment with ultrasound in the management of secondary postpartum haemorrhage. | 2002 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:12206921 |
| Samsioe G et al. | Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate. | 2002 Sep-Oct | Menopause | pmid:12218722 |
| D'arcangues C | Once-a-month estrogen/progestogen injectables. | 1991 | Entre Nous Cph Den | pmid:12222332 |
| Dugois P et al. | [Etude statistique a propos de 496 utilisatrices). (Monilial vulvovaginitis and oral contraceptives. Statistical study on 496 users)]. | 1971 | Sem Hop Paris | pmid:12229365 |
| Skarda J | Sensitivity and specificity of the bioassay of estrogenicity in mammary gland and seminal vesicles of male mice. | 2002 | Physiol Res | pmid:12234119 |
| MartÃnez C et al. | Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy. | 2002 | Br. J. Cancer | pmid:12237780 |
| Strauss JS and Pochi PE | Effect of cyclic progestin-estrogen therapy on sebum and acne in women. | 1964 | JAMA | pmid:12254865 |
| Elstein M | Low-dose progestagens as contraceptive agents. | 1970 | IPPF Med Bull | pmid:12255089 |
| Zanartu J | A new approach to fertility control: long-acting injectable progesterones. | 1968 | Adv Fertil Control | pmid:12255478 |
| Achari K | Effect of nor-ethisterone enanthate (SH 393) on the structure of the endometrium and on the cervical mucus. | 1969 | J Obstet Gynaecol India | pmid:12255497 |
| Kohorn EI et al. | The relation of the structure of progestational steroids to nucleolar differentiation in human endometrium. | 1972 | J Clin Endocrinol | pmid:12256658 |
| Salum R et al. | [Endometrial effects of norethindrone in daily uninterrupted microdoses]. | 1971 | J Bras Ginecol | pmid:12256722 |
| Yassin S et al. | Ovarian morphological changes with injectable contraceptives and their relation to cycle control. | 1971 | Ain Shams Med J | pmid:12256861 |
| Bur Ge Gonzalez Pena M and Lucheta Y Luis Antelo | [Histopathological changes of the Fallopian tubes during treatment with norethisterone enanthate]. | 1970 Nov-Dec | Obstet Ginecol Lat Am | pmid:12259091 |
| Ferrari AN et al. | [Use of norethindrone .35 mg in disorders of the menstrual cycle]. | 1970 | J Bras Ginecol | pmid:12259292 |
| Soutoul JH et al. | [Comparative study of 4 microdose progestagen - only non-stop oral contraceptives (lynestrenol, D-norgestrel, norethisterone acetate, norgestrienone) on 483 women and 4358 cycles)]. | 1976 | Contracept Fertil Sex (Paris) | pmid:12259520 |
| Contraceptive pellet: small size but long life. | 1977 | JAMA | pmid:12259968 | |
| Serfaty D et al. | [Cerebral vascular damage during a treatment with progestin alone (two cases) (author's transl)]. | 1979 | Contracept Fertil Sex (Paris) | pmid:12261669 |
| Loo JC and Brien R | Analysis of norethindrone in plasma by high-performance liquid chromatography. | 1981 | J. Liq. Chromatogr. | pmid:12262593 |
| Sri Lanka pill and vitamin trial produces important data. | 1981 | Netw Res Triangle Park N C | pmid:12263432 | |
| Prema K | Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs. | 1982 | Contracept Deliv Syst | pmid:12264126 |
| Giwa-osagie OF and Newton JR | Injectable norethisterone enanthate contraception: absence of an effect on oral glucose tolerance. | 1982 | Contracept Deliv Syst | pmid:12264129 |